Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Coagulation Factor VIII (F8) (Factor 8) antibody

Antigen

Coagulation Factor VIII (F8)

Synonyms AHF, F8B, F8C, HEMA, FVIII, DXS1253E, F8, Cf8, Cf-8, fb61d02, wu:fb61d02
Epitope
Alternatives

Factor 8

Clonality Monoclonal (F8-86)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human

Application
Alternatives Immunohistochemistry (IHC)
2 references available
Catalog no. ABIN99037
Quantity 1ml  (100ug/ml approximately)  (Variants)
Price 276.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name Factor VIII (Factor 8)
Immunogen Von Willebrand factor isolated from human plasma.
Format Supernatant
Isotype IgG1 kappa  (Matching secondary antibodies)
Clone F8-86
Specificity This antibody reacts with Von Willebrand factor in endothelial cells. It also reacts with megakaryocytes in human bone marrow. Proteolytic enzyme digestion of formalin fixed paraffin embedded tissue sections is required prior to immunostaining.

Application Details

Application Notes Titer/Working Dilution: This antibody may be diluted to a titer of 1:15-1:30 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Positive Control: Tonsil. Cellular localization: Cytoplasmic
Concentration 100ug/ml approximately
Buffer This antibody is supplied as tissue culture supernatant containing sodium azide as preservative.
Storage Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
Research Area Coagulation
Restrictions For Research Use. CE-certified for In Vitro Diagnostics (IVD) Use in the European Union

Publications

Publications Hruban, Kuhajda, Mann: "Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia." in: American journal of clinical pathology, Vol. 88, Issue 5, pp. 578-88, 1987 (PubMed).

Naiem, Gerdes, Abdulaziz et al.: "The value of immunohistological screening in the production of monoclonal antibodies." in: Journal of immunological methods, Vol. 50, Issue 2, pp. 145-60, 1982 (PubMed).